Fampyra



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 33.6%
Gait Disturbance 28.8%
Multiple Sclerosis 23.3%
Neuralgia 2.1%
Secondary Progressive Multiple Sclerosis 2.1%
Progressive Multiple Sclerosis 1.4%
Drug Use For Unknown Indication 0.7%
Abdominal Pain 0.7%
Asthenia 0.7%
Autoimmune Hepatitis 0.7%
Cystitis 0.7%
Drug Use For Unknown Indication 0.7%
Muscle Spasticity 0.7%
Paraesthesia 0.7%
Paraparesis 0.7%
Relapsing-remitting Multiple Sclerosis 0.7%
Rib Fracture 0.7%
Spinocerebellar Ataxia 0.7%
Trigeminal Neuralgia 0.7%
Convulsion 16.7%
Epilepsy 9.3%
Grand Mal Convulsion 7.4%
Multiple Sclerosis Relapse 7.4%
Myocardial Infarction 7.4%
Status Epilepticus 7.4%
Dizziness 5.6%
Rash 5.6%
Urinary Tract Infection 5.6%
Vomiting 5.6%
Death 3.7%
Headache 3.7%
Abdominal Pain Upper 1.9%
Abortion Spontaneous 1.9%
Appendicitis 1.9%
Atrial Fibrillation 1.9%
Blood Iron Decreased 1.9%
Breast Cancer 1.9%
Carotid Artery Stenosis 1.9%
Cerebral Haematoma 1.9%
Secondary
Product Used For Unknown Indication 46.9%
Multiple Sclerosis 21.9%
Gait Disturbance 15.6%
Neuralgia 6.3%
Hypertension 3.1%
Hypothyroidism 3.1%
Sleep Disorder 3.1%
Status Epilepticus 33.3%
Atrial Fibrillation 16.7%
Carotid Artery Stenosis 16.7%
Convulsion 16.7%
Ischaemic Stroke 16.7%
Concomitant
Multiple Sclerosis 44.8%
Relapsing-remitting Multiple Sclerosis 12.2%
Gait Disturbance 11.0%
Product Used For Unknown Indication 9.9%
Depression 2.8%
Muscle Spasticity 2.8%
Neuralgia 2.8%
Blood Triglycerides Increased 2.2%
Pain 2.2%
Bladder Disorder 1.1%
Gastrooesophageal Reflux Disease 1.1%
Insomnia 1.1%
Osteoporosis 1.1%
Paraesthesia 1.1%
Restless Legs Syndrome 1.1%
Anticoagulant Therapy 0.6%
Arthralgia 0.6%
Autoimmune Hepatitis 0.6%
Contraception 0.6%
Fatigue 0.6%
Convulsion 10.8%
Femoral Neck Fracture 8.1%
Subdural Haematoma 8.1%
Acute Myocardial Infarction 5.4%
Atrial Fibrillation 5.4%
Cervix Carcinoma Stage 0 5.4%
Completed Suicide 5.4%
Electrocardiogram Qt Prolonged 5.4%
Multiple Sclerosis Relapse 5.4%
Progressive Multifocal Leukoencephalopathy 5.4%
Secondary Progressive Multiple Sclerosis 5.4%
Tremor 5.4%
Urinary Tract Infection 5.4%
Asthma 2.7%
B-cell Lymphoma 2.7%
Benign Prostatic Hyperplasia 2.7%
Breast Cancer 2.7%
Cerebrovascular Accident 2.7%
Electrocardiogram St Segment Depression 2.7%
Epilepsy 2.7%